慢性肠病与SLCO2A1基因相关的
Junji Umeno1, Motohiro Esaki2, Keiichi Uchida3
1Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Inflammatory intestinal diseases
|July 28, 2025
概括
与SLCO2A1基因 (CEAS) 相关的慢性肠道病变会导致肠道,贫血和低蛋白血症. 诊断包括基因检测和成像,目前的治疗侧重于症状管理,因为缺乏确定的疗法.
科学领域:
- 胃肠病学 胃肠病学
- 遗传学 遗传学是一种遗传学.
- 罕见疾病 罕见疾病
背景情况:
- 与SLCO2A1基因 (CEAS) 相关的慢性肠病是一种罕见的遗传性疾病.
- 它的特点是小肠,慢性贫血和低蛋白质血.
- 与典型的自体逆行性疾病不同,CEAS主要影响女性,可能出现肠外表现.
研究的目的:
- 提供CEAS的全面审查.
- 强调日本新建立的诊断协议.
- 总结当前对流行病学,病因发生,临床特征,诊断和管理的理解.
主要方法:
- 审查关于CEAS的现有文献.
- 重点是诊断标准和SLCO2A1突变的遗传检测.
- 讨论症状管理和治疗干预措施.
主要成果:
- CEAS表现为小肠,缺铁性贫血和低蛋白质血.
- 观察到尿道前列腺素代谢物水平升高.
- 确认SLCO2A1突变的基因检测,特别是c.940 + 1G>A,对于诊断至关重要.
结论:
- 在患有不明原因小肠,贫血和低蛋白血症的患者中,应该怀疑CEAS.
- 准确的诊断依赖于对SLCO2A1突变的基因测试和小肠形态评估.
- 目前的治疗方法仅限于症状管理和手术,需要进一步研究有效的治疗方法.
相关概念视频
Glucose Transporters
24.1K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
24.1K
Cystic Fibrosis: Pathogenesis
366
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
366
Pleiotropy
41.1K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
41.1K
Inborn Errors of Metabolism
244
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
244
Chronic Bowel Disorders: Introduction
541
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
541
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K


